Pfizer awarded $3.5 billion contract by U.S. Army to produce COVID-19 vaccines
Seeking Alpha2021-08-03
- The Pentagon said on Monday that the U.S. Army has awarded Pfizer a contract valued at $3.5B to manufacture 500M doses of the vaccine developed by the company in partnership with BioNTech SE, New York Postreports.
- The vaccine deliveries will be earmarked for distribution around the world by the end of next year. Pfizer’s messenger-RNA-based vaccine became the first COVID-19 shot to win the FDA's emergency use authorization in December last year.
- A few days later, the U.S. government increased its order size for the vaccine by 100M doses, bringing the total number of its orders to 200M doses.
- In June, it was reported that Pfizer (PFE) agreed to supply the federal government with 500M doses of the vaccine with an option for another 200M doses.
- The company was set to make the deliveries at a not-for-profit basis, unlike the $19.50 per shot paid by the U.S. in the initial contract.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.